Sana Biotechnology (SANA)

• Market cap: $1.21B
• 1 day: 0.88%
• 5 days: 8.31%
• 1 month: 4.83%
• 3 months: 2.47%
• 6 months: 12.59%
• Year to date: 8.83%
• 1 year: 24.59%
• 5 years: -87.01%
• 10 years: -87.01%
• Sector: Healthcare
• Industry: Biotechnology

About: Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Employees: 194